ABL2
Entrez ID: 27
Full name: ABL proto-oncogene 2, non-receptor tyrosine kinase
External links: HGNC UniprotKB Ensembl RefSeq COSMIC
Family: TK: Abl
Chromosomal location: 1q25.2
Substructure location: Gatekeeper: [N/A] A-loop: [N/A] G-loop: 291...302 αC-helix: 294...297
Please click HERE
for better display.
ABL2
Non-receptor tyrosine-protein kinase that plays an ABL1-overlapping role in key processes linked to cell growth and survival such as cytoskeleton remodeling in response to extracellular stimuli, cell motility and adhesion and receptor endocytosis. Coordinates actin remodeling through tyrosine phosph...
Non-receptor tyrosine-protein kinase that plays an ABL1-overlapping role in key processes linked to cell growth and survival such as cytoskeleton remodeling in response to extracellular stimuli, cell motility and adhesion and receptor endocytosis. Coordinates actin remodeling through tyrosine phosphorylation of proteins controlling cytoskeleton dynamics like MYH10 (involved in movement); CTTN (involved in signaling); or TUBA1 and TUBB (microtubule subunits). Binds directly F-actin and regulates actin cytoskeletal structure through its F-actin-bundling activity. Involved in the regulation of cell adhesion and motility through phosphorylation of key regulators of these processes such as CRK, CRKL, DOK1 or ARHGAP35. Adhesion-dependent phosphorylation of ARHGAP35 promotes its association with RASA1, resulting in recruitment of ARHGAP35 to the cell periphery where it inhibits RHO. Phosphorylates multiple receptor tyrosine kinases like PDGFRB and other substrates which are involved in endocytosis regulation such as RIN1. In brain, may regulate neurotransmission by phosphorylating proteins at the synapse. ABL2 acts also as a regulator of multiple pathological signaling cascades during infection. Pathogens can highjack ABL2 kinase signaling to reorganize the host actin cytoskeleton for multiple purposes, like facilitating intracellular movement and host cell exit. Finally, functions as its own regulator through autocatalytic activity as well as through phosphorylation of its inhibitor, ABI1.
View more >>
GO - Biological processes (BP):
cell adhesion, cellular protein modification process, cellular response to retinoic acid, exploration behavior, negative regulation of Rho protein signal transduction, peptidyl-tyrosine phosphorylation, positive regulation of cytosolic calcium ion concentration, positive regulation of neuron project...
cell adhesion, cellular protein modification process, cellular response to retinoic acid, exploration behavior, negative regulation of Rho protein signal transduction, peptidyl-tyrosine phosphorylation, positive regulation of cytosolic calcium ion concentration, positive regulation of neuron projection development, positive regulation of oxidoreductase activity, positive regulation of phospholipase C activity, regulation of actin cytoskeleton reorganization, regulation of apoptotic process, regulation of autophagy, regulation of cell adhesion, regulation of cell motility, regulation of endocytosis, signal transduction
View more >>
GO - Molecular function (MF):
actin filament binding, actin monomer binding, ATP binding, magnesium ion binding, manganese ion binding, non-membrane spanning protein tyrosine kinase activity, phosphotyrosine residue binding, protein kinase activity, protein tyrosine kinase activity...
actin filament binding, actin monomer binding, ATP binding, magnesium ion binding, manganese ion binding, non-membrane spanning protein tyrosine kinase activity, phosphotyrosine residue binding, protein kinase activity, protein tyrosine kinase activity
View more >>
GO - Cellular component (CC):
actin cytoskeleton, cytosol, cell...
actin cytoskeleton, cytosol, cell
View more >>
ABL proto-oncogene 2, non-receptor tyrosine kinase
Control panel
Show dataset:
Show substructure:
All sites
Gatekeeper
A-loop
G-loop
αC-helix
Gatekeeper
A-loop
G-loop
αC-helix
Filter mutation sites
All sites
Minimum 5 samples
Minimum 10 samples
Minimum 5 samples
Minimum 10 samples
Data table is loading....
Kaplan plot for ABL2 in
Download patient group data (Lower:Upper = 50%:50%)
*NOTE: the Kaplan plots were collected from OncoLnc